Wird geladen...
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
OBJECTIVE: A randomized, placebo-controlled, double-blind, multicenter 52-week phase 2 trial of resveratrol in individuals with mild to moderate Alzheimer disease (AD) examined its safety and tolerability and effects on biomarker (plasma Aβ40 and Aβ42, CSF Aβ40, Aβ42, tau, and phospho-tau 181) and v...
Gespeichert in:
| Veröffentlicht in: | Neurology |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Lippincott Williams & Wilkins
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4626244/ https://ncbi.nlm.nih.gov/pubmed/26362286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000002035 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|